Anodyne Nanotech
Dr. Rudy Dajie is an investor in, and advisor to, varied health care and technology businesses. He advises CEOs on business growth and expansion or, as he likes to say, “Helping leaders think big.” As a former owner and CEO of Apothecare Pharmacy LLC, a large institutional pharmacy in Massachusetts serving mainly residential care providers, he greatly increased revenue and oversaw continued growth after a recapitalization and facility expansion. Dr. Dajie is also the founder and managing member of Grey Holdings I, a commercial real estate portfolio. He is a registered pharmacist who holds a doctorate in pharmacy from MCPHS University.
This person is not in the org chart
Anodyne Nanotech
Anodyne Nanotech is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company’s macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules (such as ibuprofen) for fast and sustained delivery.